GPs prescribing Mounjaro

From 23 June 2025, a new medication called Tirzepatide (brand name Mounjaro) may be available to some patients in general practice as part of a national NHS programme to support weight management.

Who is eligible?

At this time, only a small group of patients will be eligible to receive tirzepatide on an NHS prescription. You must:

• Be aged 18 or over
• Have a Body Mass Index (BMI) of 40 or higher
• Have at least four of the following five medical conditions:

1. High blood pressure (and taking medication for it)
2. Abnormal cholesterol or triglycerides (or taking treatment for these)
3. Sleep apnoea confirmed by a sleep study
4. Cardiovascular disease (e.g. heart attack, stroke, peripheral vascular disease, or heart failure)
5. Type 2 diabetes

If you do not meet all of these criteria, you are not eligible for this medication at this stage.

This is part of a phased national NHS rollout. Only the highest-risk patients are eligible initially. Over time, more groups may become eligible. We will update you if that happens.

Find out more here.

Published: Jun 24, 2025